Advances in the Multimodal Management of Pancreatic Ductal Adenocarcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 37
Special Issue Editors
Interests: pancreatic cancer; hepatobiliary cancer; phase II/III trials; symptom management
Special Issues, Collections and Topics in MDPI journals
Interests: pancreatic cancer; clinical trials; biomarkers
Interests: pancreatic cancer; clinical trials; pathology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with limited survival outcomes despite advances in cancer care. Growing evidence underscores the necessity of a multimodal approach—combining surgery, systemic therapy, radiotherapy, and emerging targeted strategies—to meaningfully improve patient outcomes.
This Special Issue, “Advances in the Multimodal Management of Pancreatic Ductal Adenocarcinoma”, brings together original research, clinical studies, translational science, and expert perspectives to highlight the latest progress in this rapidly evolving field. Contributions addressing critical areas such as neoadjuvant and adjuvant therapies, biomarker-driven treatment selection, and the integration of precision oncology, immunotherapy, and novel imaging or surgical techniques are welcome. Unique research articles and technical innovations that further illustrate the potential of individualized, multidisciplinary care are also of interest. By fostering collaboration across surgical oncology, medical oncology, radiology, pathology, and translational research, this Issue aims to illuminate new pathways for improving outcomes globally and shaping the future of PDAC management.
Dr. Olav F. Dajani
Dr. Knut Jørgen Labori
Dr. Arne Westgaard
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic ductal adenocarcinoma (PDAC)
- multimodal approach
- systemic therapy
- radiotherapy
- targeted strategies
- neoadjuvant therapy
- adjuvant therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
